Retinoic acid attenuates contrast-induced acute kidney injury in a miniature pig model

Biochem Biophys Res Commun. 2019 Apr 30;512(2):163-169. doi: 10.1016/j.bbrc.2019.03.013. Epub 2019 Mar 13.

Abstract

Background: Contrast-induced acute kidney injury (CI-AKI) has been the third leading cause of hospital-acquired AKI. Retinoic acid (RA), the main derivative of vitamin A, has preventative and therapeutic effects in ischemia-reperfusion-AKI and UUO models, but little is known about its effects on CI-AKI. This study aimed to explore the effects of RA on CI-AKI as well as the underlying mechanisms.

Methods: We established a new miniature pig model of CI-AKI by catheterizing the external jugular vein and injecting a single dose of iohexol after dehydration. Bun, Scr, serum and urinary RBP and β-MG levels were measured. Renal histological, TEM examination, LDH assays, TUNEL assays, GFP-LC3 plasmid transfection and western blotting were performed.

Results: The levels of Bun, Scr, serum and urinary RBP and β-MG were increased after CI-AKI and decreased by RA pretreatment. The renal histology showed foamy degeneration and dilated tubules after CI-AKI, and the tissue damage was alleviated significantly by RA pretreatment. RA mitigated renal fibrosis after CI-AKI. In vitro, RA protected proximal TECs against iohexol-induced injury. RA inhibited TECs apoptosis and activated autophagy in vivo and in vitro.

Conclusions: RA alleviates CI-AKI and mitigates renal fibrosis after CI-AKI. Autophagy activation and apoptosis inhibition are involved in the protective effect of RA on CI-AKI. RA may be a new agent for the prevention and therapeutic treatment of CI-AKI in the future.

Keywords: Apoptosis; Autophagy; Contrast-induced acute kidney injury; Miniature pig; Retinoic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / pathology
  • Animals
  • Apoptosis / drug effects
  • Contrast Media / adverse effects*
  • Disease Models, Animal
  • Humans
  • Protective Agents / therapeutic use*
  • Swine
  • Swine, Miniature
  • Tretinoin / therapeutic use*

Substances

  • Contrast Media
  • Protective Agents
  • Tretinoin